![Anti–tumor necrosis factor alpha therapy (adalimumab) in Rasmussen's encephalitis: An open pilot study - Lagarde - 2016 - Epilepsia - Wiley Online Library Anti–tumor necrosis factor alpha therapy (adalimumab) in Rasmussen's encephalitis: An open pilot study - Lagarde - 2016 - Epilepsia - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/c2651ea6-bbb8-498a-a5d8-61fc1337a911/epi13387-fig-0003-m.jpg)
Anti–tumor necrosis factor alpha therapy (adalimumab) in Rasmussen's encephalitis: An open pilot study - Lagarde - 2016 - Epilepsia - Wiley Online Library
![Daniel SCHWARZ | Associate Professor | Ph.D. | Masaryk University, Brno | MUNI | Faculty of Medicine Daniel SCHWARZ | Associate Professor | Ph.D. | Masaryk University, Brno | MUNI | Faculty of Medicine](https://www.researchgate.net/profile/Ivo_Provaznik/publication/51391584/figure/fig4/AS:394043801522182@1470958771878/Estimation-of-the-joint-PDF-p-with-the-use-of-tissue-probability-maps-P-The-joint-PDF_Q320.jpg)
Daniel SCHWARZ | Associate Professor | Ph.D. | Masaryk University, Brno | MUNI | Faculty of Medicine
![Characterizing freezing of gait in Parkinson's disease: Models of an episodic phenomenon - Nieuwboer - 2013 - Movement Disorders - Wiley Online Library Characterizing freezing of gait in Parkinson's disease: Models of an episodic phenomenon - Nieuwboer - 2013 - Movement Disorders - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/f63f16ea-b002-4194-9f45-7bdcc858cdbc/mds.v28.11.cover.jpg)
Characterizing freezing of gait in Parkinson's disease: Models of an episodic phenomenon - Nieuwboer - 2013 - Movement Disorders - Wiley Online Library
![Anti–tumor necrosis factor alpha therapy (adalimumab) in Rasmussen's encephalitis: An open pilot study - Lagarde - 2016 - Epilepsia - Wiley Online Library Anti–tumor necrosis factor alpha therapy (adalimumab) in Rasmussen's encephalitis: An open pilot study - Lagarde - 2016 - Epilepsia - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/cb003576-e861-49d1-a7c4-7cc7984600f0/epi13387-fig-0001-m.jpg)
Anti–tumor necrosis factor alpha therapy (adalimumab) in Rasmussen's encephalitis: An open pilot study - Lagarde - 2016 - Epilepsia - Wiley Online Library
GPiâ•'DBS in Huntington's disease: Results on motor function and cognition in a 72â•'yearâ•'old case
![Hareth NAHI | Consultant | MD, PhD | Karolinska University Hospital, Stockholm | Karolinska | Department of Hematology Hareth NAHI | Consultant | MD, PhD | Karolinska University Hospital, Stockholm | Karolinska | Department of Hematology](https://www.researchgate.net/publication/327214153/figure/fig1/AS:873049075228677@1585162528753/Study-design_Q320.jpg)
Hareth NAHI | Consultant | MD, PhD | Karolinska University Hospital, Stockholm | Karolinska | Department of Hematology
![PDF) Childhood leukodystrophies: A literature review of updates on new definitions, classification, diagnostic approach and management PDF) Childhood leukodystrophies: A literature review of updates on new definitions, classification, diagnostic approach and management](https://www.researchgate.net/profile/Mahmoudreza_Ashrafi/publication/312663401/figure/fig3/AS:457284993196034@1486036646920/Schematic-approach-to-brain-MRI-suspicius-of-genetic-leukoencephalopathy-or_Q320.jpg)
PDF) Childhood leukodystrophies: A literature review of updates on new definitions, classification, diagnostic approach and management
![PDF) Childhood leukodystrophies: A literature review of updates on new definitions, classification, diagnostic approach and management PDF) Childhood leukodystrophies: A literature review of updates on new definitions, classification, diagnostic approach and management](https://www.researchgate.net/profile/Mahmoudreza_Ashrafi/publication/312663401/figure/tbl1/AS:667935450361861@1536259629307/mportant-neurologic-features-of-leukodystrophies_Q320.jpg)
PDF) Childhood leukodystrophies: A literature review of updates on new definitions, classification, diagnostic approach and management
![CXCL12 and CXCR7 are relevant targets to reverse cell adhesion‐mediated drug resistance in multiple myeloma - Waldschmidt - 2017 - British Journal of Haematology - Wiley Online Library CXCL12 and CXCR7 are relevant targets to reverse cell adhesion‐mediated drug resistance in multiple myeloma - Waldschmidt - 2017 - British Journal of Haematology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/9b8f1be9-e8fe-463d-9350-b6a01c41b093/bjh14807-fig-0002-m.jpg)
CXCL12 and CXCR7 are relevant targets to reverse cell adhesion‐mediated drug resistance in multiple myeloma - Waldschmidt - 2017 - British Journal of Haematology - Wiley Online Library
![Jorge CASTILLO | Hematologist and Oncologist | Dana-Farber Cancer Institute, Boston | DFCI | Bing Center for Waldenstrom's Macroglobulinemia - Page 2 Jorge CASTILLO | Hematologist and Oncologist | Dana-Farber Cancer Institute, Boston | DFCI | Bing Center for Waldenstrom's Macroglobulinemia - Page 2](https://www.researchgate.net/profile/Jorge_Castillo3/publication/307557438/figure/tbl3/AS:669113747783682@1536540557175/Association-Between-Receipt-of-Prophylactic-G-CSF-and-Risk-of-Death-Within-30-Days-From_Q320.jpg)
Jorge CASTILLO | Hematologist and Oncologist | Dana-Farber Cancer Institute, Boston | DFCI | Bing Center for Waldenstrom's Macroglobulinemia - Page 2
![Multiple myeloma: patient outcomes in real‐world practice - Yong - 2016 - British Journal of Haematology - Wiley Online Library Multiple myeloma: patient outcomes in real‐world practice - Yong - 2016 - British Journal of Haematology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/412f11f0-2156-4c7c-a739-c8b9d547afd8/bjh14213-fig-0005-m.jpg)